In a filing, Alx Oncology Holdings Inc revealed its Interim CFO Pinto Shelly unloaded Company’s shares for reported $3998.0 on Jan 06 ’25. In the deal valued at $1.80 per share,2,221 shares were sold. As a result of this transaction, Pinto Shelly now holds 87,902 shares worth roughly $0.14 million.
Then, Pinto Shelly sold 1,426 shares, generating $2,253 in total proceeds. Upon selling the shares at $1.58, the Interim CFO now owns 90,123 shares.
Before that, Pons Jaume sold 10,796 shares. Alx Oncology Holdings Inc shares valued at $17,060 were divested by the PRESIDENT & CSO at a price of $1.58 per share. As a result of the transaction, Pons Jaume now holds 580,714 shares, worth roughly $0.92 million.
Jefferies downgraded its Alx Oncology Holdings Inc [ALXO] rating to a Hold from a a Buy in a research note published on December 19, 2024; the price target was decreased to $2 from $12. A number of analysts have revised their coverage, including Stifel’s analysts, who decreased its forecast for the stock in early March from “a Buy” to “a Hold”. Jefferies also remained covering ALXO and has increased its forecast on December 08, 2023 with a “Buy” recommendation from previously “Hold” rating. Jefferies revised its rating on December 22, 2021. It rated ALXO as “a Hold” which previously was an “a Buy”.
Price Performance Review of ALXO
On Tuesday, Alx Oncology Holdings Inc [NASDAQ:ALXO] saw its stock fall -5.92% to $1.59. Over the last five days, the stock has lost -11.17%. Alx Oncology Holdings Inc shares have fallen nearly -4.79% since the year began. Nevertheless, the stocks have fallen -88.68% over the past one year. While a 52-week high of $17.83 was reached on 01/08/25, a 52-week low of $1.19 was recorded on 01/03/25. SMA at 50 days reached $1.5576, while 200 days put it at $5.6802.
Levels Of Support And Resistance For ALXO Stock
The 24-hour chart illustrates a support level at 1.5247, which if violated will result in even more drops to 1.4593. On the upside, there is a resistance level at 1.7107. A further resistance level may holdings at 1.8313. The Relative Strength Index (RSI) on the 14-day chart is 46.79, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0495, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.30%. Stochastics %K at 37.29% indicates the stock is a holding.
How much short interest is there in Alx Oncology Holdings Inc?
A steep rise in short interest was recorded in Alx Oncology Holdings Inc stocks on 2024-12-31, growing by 0.43 million shares to a total of 7.6 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 7.17 million shares. There was a rise of 5.63%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on September 30, 2021 when Stifel began covering the stock and recommended ‘”a Buy”‘ rating along with a $106 price target.
